Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Lahontan Gold Corp.

September 19, 2025

Harmony Greenlights US$1.75 Billion Eva Copper Mine Bildout

November 25, 2025

Standard Uranium Retains 100% Unencumbered Ownership of the...

December 12, 2025

Top 5 Palladium and Platinum Countries by Production

September 25, 2025

5 Best-performing Canadian Uranium Stocks of 2025

August 6, 2025

Biotech and Pharma Market Update: Q2 2025 in...

July 25, 2025

Osisko Intersects 748 Metres Averaging 0.27% Cu at...

January 15, 2026

xU3O8 Token Launches on Major Global Trading Venues:...

July 25, 2025

New Found Gold: Emerging Canadian Gold Producer Advancing...

December 30, 2025

NorthStar Gaming to Host Q2 2025 Earnings Webinar...

August 8, 2025